Chitotriosidase: The yin and yang

Cellular and Molecular Life Sciences

Volumn 63, Issue 24, 2006, Pages 3018-3029

  Malaguarnera, L ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

thalassemia; Atherosclerosis; Chitotriosidase; Gaucher's disease; Immunity; Neurodegenerative disorders; Non alcoholic steatohepatitis; Plasmodium falciparum malaria

Indexed keywords

ANTIFUNGAL AGENT; ATORVASTATIN; BEZAFIBRATE; CHITINASE; CHITOTRIOSIDASE; RECOMBINANT CHITOTRIOSIDASE; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ASTHMA; ATHEROSCLEROSIS; CELL FUNCTION; CHINESE MEDICINE; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME STRUCTURE; ENZYME SYNTHESIS; GAUCHER DISEASE; HUMAN; IMMUNITY; LYSOSOME STORAGE DISEASE; MACROPHAGE ACTIVATION; MALARIA; MYCOSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARASITOSIS; REVIEW; THALASSEMIA;

ASTHMA; ATHEROSCLEROSIS; DISEASE SUSCEPTIBILITY; GAUCHER DISEASE; GENE FREQUENCY; HEPATITIS; HEXOSAMINIDASES; HUMANS; IMMUNITY, NATURAL; MALARIA; NEURODEGENERATIVE DISEASES; PARASITIC DISEASES; POLYMORPHISM, GENETIC; THALASSEMIA; YIN-YANG;

PLASMODIUM FALCIPARUM; VERTEBRATA;

EID: 33846083753     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6269-2     Document Type: Review

References (99)

1. Hollak, C. E., van Weely, S., van Oers, M. H. and Aerts, J. M. (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 93, 1288-1292.
2. Brinkman, J., Wijburg, F. A., Hollak, C. E., Groener, J. E., Verhoek, M., Scheij, S., Aten, J., Boot, R. G. and Aerts, J. M. (2005) Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease. J. Inherit. Metab. Dis. 28, 13-20.
3. Michelakakis, H., Dimitriou, E. and Labadaridis, I. (2004) The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update. J. Inherit. Metab. Dis. 27, 705-706.
4. Guo, Y., He, W., Boer, A. M., Wevers, R. A., de Bruijn, A. M., Groener, J. E., Hollak, C. E., Aerts, J. M., Galjaard, H. and van Diggelen, O. P. (1995) Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J. Inherit. Metab. Dis. 18, 717-722.
5. Boot, R. G., van Achterberg, T. A., van Aken, B. E., Renkema, G. H., Jacobs, M. J., Aerts, J. M. and de Vries, C. J. (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 687-694.
6. Artieda, M., Cenarro, A., Ganan, A., Jerico, I., Gonzalvo, C., Casado, J. M., Vitoria, I., Puzo, J., Pocovi, M. and Civeira, F. (2003) Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler. Thromb. Vasc. Biol. 23, 1645-1652.
7. Canudas, J., Cenarro, A., Civeira, F., Garci-Otin, A. L., Aristegui, R., Diaz, C., Masramon, X., Sol, J. M., Hernandez, G. and Pocovi, M. (2001) Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism 50, 447-450.
8. Barone, R., Simporè J., Malaguarnera, L., Pignatelli, S. and Musumeci, S. (2003) Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin. Chim. Acta 331, 79-85.
9. Barone, R., Di Gregorio, F., Romeo, M. A., Schiliro, G. and Pavone, L. (1999) Plasma chitotriosidase activity in patients with β-thalassemia. Blood Cells Mol. Dis. 15, 1-8.
10. Malaguarnera, L., Musumeci, M., Licata, F., Di Rosa, M., Messina, A. and Musumeci, S. (2004) Prolactin induces chitotriosidase gene expression in human monocyte-derived macrophages. Immunol. Lett. 94, 57-63.
11. Malaguarnera, L., Musumeci, M., Di Rosa, M., Scuto, A. and Musumeci, S. (2005) Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J. Clin. Lab. Anal. 19, 128-132.
12. Di Rosa, M., Musumeci, M., Scuto, A., Musumeci, S. and Malaguarnera, L. (2005) Effect of interferon-gamma, interleukin 10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages. Clin. Chem. Lab. Med. 43, 499-502.
13. Malaguarnera, L., Di Rosa, M., Zambito, A. M., Dell'Ombra, N., Nicoletti, F. and Malaguarnera, M. (2006) Chitotriosidase gene expression in Kupffer cells of non-alcoholic fatty liver disease patients. Gut 55, 1313-1320.
14. Malaguarnera, L., Di Rosa, M., Zambito, A. M., Dell'Ombra, N., Di Marco, R. and Malaguarnera, M. (2006) Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. Am. J. Gastroenterol. 101, 2060-2069.
15. Di Rosa, M., Dell'Ombra, N., Zambito, A. M., Malaguarnera, M., Nicoletti, F. and Malaguarnera, L. (2006) Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur. J. Neurosci. 23, 2648-2656.
16. Boot, R. G., Renkema, G. H., Verhoek, M., Strijland, A., Bliek, J., de Meulemeester, T. M., Mannens, M. M. and Aerts, J. M. (1998) The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem. 273, 25680-25685.
17. Boot, R. G., Blommaart, E. F., Swart, E., Ghauharali-van der Vlugt, K., Bijl, N., Moe, C., Place, A. and Aerts, J. M. (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem. 276, 6770-6778.
18. Henrissat, B. and Bairoch, A. (1993) New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 293, 781-788.
19. Boot, R. G., Renkema, G. H., Strijland, A., van Zonneveld, A. J. and Aerts, J. M. (1995) Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 270, 26252-26256.
20. Kuranda, M. J. and Robbins, P. W. (1991) Chitinase is required for cell separation during growth of Saccharomyces cerevisiae. J. Biol. Chem. 266, 19758-19767.
21. Wu, Y., Egerton, G., Underwood, A. P., Sakuda, S. and Bianco, A. E. (2001) Expression and secretion of a larval-specific chitinase (family 18 glycosylhydrolase) by the infective stages of the parasitic nematode, Onchocerca volvulus. J. Biol. Chem. 276, 42557-42564.
22. Vinetz, J. M., Dave, S. K., Specht, C. A., Brameld, K. A., Xu, B., Hayward, R. and Fidock, D. A. (1999) The chitinase PfCHT1 from the human malaria parasite Plasmodium falciparum lacks proenzyme and chitin-binding domains and displays unique substrate preferences. Proc. Natl. Acad. Sci. USA 96, 14061-14066.
23. Cohen, E. (1993) Chitin synthesis and degradation as targets for pesticide action. Arch. Insect Biochem. Physiol. 22, 245-261.
24. Eiberg, H. and Den Tandt, W. R. (1997) Assignment of human plasma methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase or chitinase to chromosome 1q by a linkage study. Hum. Genet. 101, 205-207.
25. Boussac, M. and Garin, J. (2000) Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 21, 665-672.
26. Renkema, G. H., Boot, R. G., Muijsers, A. O., Donker-Koopman, W. E. and Aerts, J. M. (1995) Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J. Biol. Chem. 270, 2198-21202.
27. Renkema, G. H., Boot, R. G., Strijland, A., Donker-Koopman, W. E., van den Berg, M., Muijsers, A. O. and Aerts, J. M. (1997) Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur. J. Biochem. 244, 279-285.
28. Fusetti, F., von Moeller, H., Houston, D., Rozeboom, H. J., Dijkstra, B. W., Boot, R. G., Aerts, J. M. and van Aalten, D. M. (2002) Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. J. Biol. Chem. 277, 25537-25544.
29. Arias, E. B., Verhage, H. G. and Jaffe, R. C. (1994) Complementary deoxyribonucleic acid cloning and molecular characterization of an estrogen-dependent human oviductal glycoprotein. Biol. Reprod. 51, 685-694.
30. Hakala, B. E., White, C. and Recklies, A. D. (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J. Biol. Chem. 268, 25803-25810.
31. Hu, B., Trinh, K., Figueira, W. F. and Price, P. A. (1996) Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family, J. Biol. Chem. 271, 19415-19420.
32. Saito, A., Ozaki, K., Fujiwara, T., Nakamura, Y. and Tanigami, A. (1999) Isolation and mapping of a human lung-specific gene, TSA1902, encoding a novel chitinase family member. Gene 239, 325-331.
33. Owhashi, M., Arita, H. and Hayai, N. (2000) Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J. Biol. Chem. 275, 1279-1286.
34. Malinda, K. M., Ponce, L., Kleinman, H. K., Shackelton, L. M. and Millis, A. J. (1999) Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp. Cell Res. 250, 168-173.
35. Chou, Y. T, Yao, S., Czerwinski, R., Fleming, M., Krykbaev, R., Xuan, D., Zhou, H., Brooks, J., Fitz, L., Strand, J., Presman, E., Lin, L., Aulabaugh, A. and Huang, X. (2006) Kinetic characterization of recombinant human acidic mammalian chitinase. Biochemistry. 45, 4444-4454.
36. Beutler, E. and Grabowski, D. A. (2001) Gaucher disease, in: The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Eds), pp. 3635-3656. McGraw-Hill, New York.
37. Esplin, J. A. (1994) Overview: Gaucher disease, molecular, medicine and therapeutics. Gauch. Clin. Perspect. 2, 1-16.
38. Hollak, C. E., Maas, M. and Aerts, J. M. (2001) Clinically relevant therapeutic endpoints in type 1 Gaucher disease. J. Inherit. Metab. Dis. 24 [Suppl. 2], 97-105.
39. Rodrigues, M. R., Sa Miranda, M. C. and Amaral, O. (2004) Allelic frequency determination of the 24-bp chitotriosidase duplication in the Portuguese population by real-time PCR. Blood Cells Mol. Dis. 33, 362-364.
40. van Aalten, D. M., Komander, D., Synstad, B., Gaseidnes, S., Peter, M. G. and Eijsink, V. G. (2001) Structural insights into the catalytic mechanism of a family 18 exochitinase. Proc. Natl. Acad. Sci. USA 98, 8979-8984.
41. Papanikolau, Y., Prag, G., Tavlas, G., Vorgias, C. E., Oppenheim, A. B. and Petratos, K. (2001) High resolution structural analyses of mutant chitinase A complexes with substrates provide new insight into the mechanism of catalysis. Biochemistry 40, 11338-11343.
42. Malaguarnera, L., Simpore, J., Prodi, D. A., Angius, A., Sassu, A., Persico, I., Barone, R. and Musumeci, S. (2003) A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun. 4, 570-574.
43. Choi, E. H., Zimmerman, P. A., Foster, C. B., Zhu, S., Kumaraswami, V., Nutman, T. B. and Chanock, S. J. (2001) Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun. 2, 248-253.
44. Weatherall, D. J. and Abdalla, S. (1982) The anaemia of Plasmodium Falciparum malaria. Br. Med. Bull. 38, 147-151.
45. Weiss, L. (1990) The spleen in malaria: the role of barrier cells. Immunol. Lett. 25, 165-172.
46. Kwiatkowski, D. (1999) The molecular genetic approach to malarial pathogenesis and immunity. Parassitologia 41, 233-240.
47. Bazan, J. F. (1989) A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 164, 788-795.
48. O'Neal, K. D., Schwarz, L. A. and Yu-Lee L-Y. (1992) Prolactin receptor gene expression in lymphoid cells. Mol. Cell. Endocrinol. 82, 127-135.
49. Kooijman, R., Hooghe-Peters, E. L. and Hooghe, R. (1996) Prolactin, growth hormone, and insulin-like growth factor-1 in the immune system. Adv. Immunol. 63, 377-454.
50. Hashimoto, S., Suzuki, T., Dong, H. Y., Yamazaki, N. and Matsushima, K. (1999) Serial analysis of gene expression in human monocytes and macrophages. Blood 94, 837-844.
51. Jones, T. C. (1999) Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections. Eur. J. Cancer 35 Suppl. 3, S8-10.
52. Lauw, F. N., te Velde, A. A., Dekkers, P. E., Speelman, P., Aerts, J. M., Hack, C. E., van Deventer, S. J. and van der Poll, T. (1999) Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzees. J. Clin. Immunol. 19, 231-232.
53. Romani, L., Puccetti, P. and Bistoni, F. (1997) Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10, 611-636.
54. Malaguarnera, L., Imbesi, R. M., Pignatelli, S., Simpore, J., Malaguarnera, M. and Musumeci, S. (2002) Increased levels of interleukin-12 in Plasmodium falciparum malaria: correlation with the severity of disease. Parasite Immunol. 24, 387-389.
55. Labadaridis, I., Dimitriou, E., Theodorakis, M., Kafalidis, G., Velegraki, A. and Michelakakis, H. (2005) Chitotriosidase in neonates with fungal and bacterial infections. Arch. Dis. Child. Fetal Neonatal Ed. 90, F531-532.
56. van Eijk, M., van Roomen, C. Pl, Renkema, G. H., Bussink, A. P., Andrews, L., Blommaart, E. F., Sugar, A., Verhoeven, A. J., Boot, R. G. and Aerts, J. M. (2005) Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int. Immunol. 17, 1505-1512.
57. Lehrnbecher, T., Bernig, T., Hanisch, M., Koehl, U., Behl, M., Reinhardt, D., Creutzig, U., Klingebiel, T., Chanock, S. J. and Schwabe, D. (2005) Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 19, 1745-1750.
58. Briton-Jones, C., Lok, I. H., Yuen, P. M., Chiu, T. T., Cheung, L. P. and Haines, C. (2001) Regulation of human oviductin mRNA expression in vivo. Fertil. Steril. 75, 942-946.
59. van Bilsen, J. H., van Dongen, H., Lard, L. R, van der Voort, E. I, Elferink, D. G, Bakker, A. M., Miltenburg, A. M., Huizinga, T. W., de Vries, R. R. and Toes, R. E. (2004) Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 101, 17180-17185.
60. Ling, H. and Recklies, A. D. (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem. J. 380, 651-659.
61. Tsuruha, J., Masuko-Hongo, K., Kato, T., Sakata, M., Nakamura, H., Sekine, T., Takigawa, M. and Nishioka, K. (2002) Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis. J. Rheumatol. 29, 1459-1466.
62. Zhu, Z., Zheng, T., Homer, R. J., Kim, Y. K., Chen, N. Y., Cohn, L., Hamid, Q. and Elias, J. A. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304, 1678-1682.
63. Bierbaum, S., Nickel, R., Koch, A., Lau, S., Deichmann, K. A, Wahn, U., Superti-Furga, A. and Heinzmann, A. (2005) Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am. J. Respir. Crit. Care Med. 172, 1505-1509.
64. Bierbaum, S., Superti-Furga, A. and Heinzmann, A. (2006) Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int. J. Immunogenet. 33, 201-204.
65. Boot, R. G., Bussink, A. P., Verhoek, M., de Boer, P. A., Moorman, A. F. and Aerts, J. M. (2005) Marked differences in tissue-specific expression of chitinases in mouse and man. J. Histochem. Cytochem. 53, 1283-1292.
66. Altarescu, G., Rudensky, B., Abrahamov, A., Goldfarb, A., Rund, D., Zimran, A. and Elstein, D. (2002) Plasma chitotriosidase activity in patients with beta-thalassemia. Am. J. Hematol. 71, 7-10.
67. Giardina, P. J. and Grady, R. W. (1995) Chelation therapy in β-thalassemia: the benefits and limitations of desferrioxamine. Semin. Hematol. 32, 304-312.
68. Tong Mak, I. and Weglicki, E. B. (1985) Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes. J. Clin. Invest. 75, 58-63.
69. Rachmilewitz, E. A., Kornberg, A. and Acker, M. (1982) Vitamin E deficiency due to increased consumption in β-thalassemia and in Gaucher disease. Ann. N. Y. Acad. Sci. 393, 336-347.
70. Wiener, E., Wanachiwanawin, W., Chinprasertsuk, S., Siripanyaphinyo, U., Mawas, F., Fucharoen, S. and Wickramasinghe, S. N. (1996) Increased serum levels of macrophage colony-stimulating factor (M-CSF) in alpha- and beta-thalassaemia syndromes: correlation with anaemia and monocyte activation. Eur. J. Haematol. 57, 364-369.
71. Aerts, J. M. and Hollak, C. E. (1997) Plasma and metabolic abnormalities in Gaucher's disease. Baillieres Clin. Haematol. 10, 691-709.
72. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126.
73. Young, J. L., Libby, P. and Schonbeck, U. (2002) Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemost. 88, 554-567.
74. Libby, P., Ridker, P. M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
75. Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V. and Fallon, J. T. (1994) Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90, 775-778.
76. Chong, Z. Z., Li, F. and Maiese, K. (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res. Brain Res. Rev. 49, 1-21.
77. Luth, H. J., Munch, G. and Arendt, T. (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res. 953, 135-143.
78. Wong, A., Luth, H. J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T. and Munch, G. (2001) Advanced glycation endproducts colocalize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 920, 32-40.
79. McGeer, E. G. and McGeer, P. L. (2001) Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. Mol. Interv. 1, 22-29.
80. Dirnagl, U., Iadecola, C. and Moskowitz, M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
81. Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q. and Lee, V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183-4187.
82. + T-lymphocytes and activated microglia/macrophages. J. Neuroimmunol. 114, 232-241.
83. Palasik, W., Fiszer, U., Lechowicz, W., Czartoryska, B., Krzesiewicz, M. and Lugowska, A. (2005) Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol. 53, 188-193.
84. Sotgiu, S., Barone, R., Zanda, B., Arru, G., Fois, M. L., Arru, A., Rosati, G., Marchetti, B. and Musumeci, S. (2005) Chitotriosidase in patients with acute ischemic stroke. Eur. Neurol. 54, 149-153.
85. Casal, J. A., Robles, A. and Tutor, J. C. (2003) Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia. Clin. Biochem. 36, 553-556.
86. Chitturi, S. and Farrell, G. C. (2001) Etiopathogenesis of non-alcoholic steatohepatitis. Semin. Liver Dis. 21, 27-41.
87. Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., Weltman, M. and George, J. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379.
88. Van Berkel, T. J. C., de Rijke, Y. B. and Kruijt, J. K. (1991) Different fat in vivo of oxidatively modified-LDL and acetylated-LDL in rats. Recognition by various scavenger receptors on Kupffer cells and endothelial liver cells. J. Biol. Chem. 266, 2282-2289.
89. De Rijke, Y. B. and Van Berkel, T. J. (1994) Rat liver Kupffer and endothelial cells express different binding proteins for modified low-density lipoproteins. Kupffer cells express a 95-kDa-membrane protein as a specific binding site for oxidized low-density lipoproteins. J Biol Chem. 269, 824-827.
90. Matsuoka, M., Zhang, M. Y. and Tsukamoto, H. (1990) Sensitisation of hepatic lipocytes by high fat diet to stimulatory effects of Kupffer cell-derived factors: Implications for fibrogenesis. Hepatology 11, 173-182.
91. Friedman, S. L. (1990) Cellular sources of collagen and regulation of collagen production in liver. Semin. Liver Dis. 10, 20-29.
92. Maher, J. J, Friedman, S. L, Roll, F. J. and Bissell, D. M. (1988) Immuno-localization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology 94, 1053-1062.
93. Rieder, H., Ramadori, G., Dienes, H. P. and Meyer zum Buschenfelde, K. H. (1987) Sinusoidal endothelial cells from guinea pig liver synthesize and secrete cellular fibronectin in vitro. Hepatology 7, 856-864.
94. Schafer, S., Zerbe, O. and Gressner, A. M. (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7, 680-687.
95. Bedossa, P., Houglum, K., Trautwein, C., Holstege, A. and Chojkier, M. (1994) Stimulation of collagen a1(I) gene expression is associated with lipid per-oxidation in hepatocellular injury: A link to tissue fibrosis? Hepatology 19, 1262-1271.
96. Meyer, M. F. and Kreil, G. (1996) Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan. Proc. Natl. Acad. Sci. USA 93, 4543-4547.
97. Varki, A. (1996) Does DG42 synthesize hyaluronan or chitin? A controversy about oligosaccharides in vertebrate development. Proc. Natl. Acad. Sci. USA 93, 4523-4525.
98. Sakugawa, H., Nakayoshi, T., Kobashigawa, K., Yamashiro, T., Maeshiro, T., Miyagi, S., Shiroma, J., Toyama, A., Nakayoshi, T., Kinjo, F. and Saito, A. (2005) Clinical usefulness of biochemical markers of liver fibrosis in patients with non-alcoholic fatty liver disease. World, J. Gastroenterol. 11, 255-259.
99. Lieber, C. S. (2004) Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34, 9-19.